DETROIT – The Food and Drug Administration’s Vaccine Advisory Committee will hold a day-long open meeting to discuss whether or not to authorize Pfizer’s COVID-19 vaccine. Starting at 9 a.m. on Thursday, the FDA will present its review of the Pfizer-BioNTech vaccine data to its independent panel of outside experts. Other expected points of discussion include the allergic reaction seen in two U.K. health care workers, the safety of mRNA vaccines, distribution plans and how the vaccine’s safety will continue to be monitored after an authorization. Do not expect to see any discussion of authorization of the vaccine for children under 16 or pregnant women. If the advisory committee votes yes, the FDA could give the green light to the Pfizer vaccine within a day or two.